St. Francis Medical Technologies Files Registration Statement For Proposed Initial Public Offering
Published: Sep 22, 2006
St. Francis Medical is a medical device company focused on the design, development and marketing of motion-preserving technologies and procedures for orthopedic and neurological spine surgery.
Citigroup Global Markets Inc. and J.P. Morgan Securities Inc. will be acting as joint bookrunning managers and Piper Jaffray & Co. and Thomas Weisel Partners LLC will be acting as co-managers. The numbers of shares to be offered and the price range have not yet been determined. This offering will be made only by means of a prospectus. Copies of the preliminary prospectus for this offering may be obtained, when available, from the prospectus departments of Citigroup Global Markets Inc. at 388 Greenwich Street, New York, NY 10012 and of J.P. Morgan Securities Inc. at Prospectus Library, 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245.
A registration statement relating to these securities has been filed with the SEC, but it has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective. This news release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification under the securities laws of any such state or jurisdiction.
This news release contains certain forward-looking statements that involve risks and uncertainties. Forward-looking statements include St. Francis Medical's plans to sell securities in an initial public offering. Such statements are only predictions and actual results may differ materially from those anticipated in these forward-looking statements.
Contact: St. Francis Medical Technologies, Inc. Michael Bates, 510-337-2621
Source: St. Francis Medical Technologies, Inc.